Cargando…
Recent Advances in Drug Design and Drug Discovery for Androgen-Dependent Diseases
This article summarizes the importance of different targets such as 5α-reductase, 17β-HSD, CYP17A, androgen receptor and protein kinase A for the treatment of prostate cancer and benign prostatic hyperplasia. It is a well known fact that dihydrotestosterone (DHT) is associated with the development o...
Autores principales: | Cabeza, Marisa, Sánchez-Márquez, Araceli, Garrido, Mariana, Silva, Aylín, Bratoeff, Eugene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412001/ https://www.ncbi.nlm.nih.gov/pubmed/26861003 http://dx.doi.org/10.2174/0929867323666160210125642 |
Ejemplares similares
-
Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020) -
Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023) -
Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
por: Shim, Joong Sup, et al.
Publicado: (2014) -
Recent advances in combinatorial biosynthesis for drug discovery
por: Sun, Huihua, et al.
Publicado: (2015) -
Recent Advancement in Drug Design and Discovery of Pyrazole Biomolecules as Cancer and Inflammation Therapeutics
por: Alam, Md. Jahangir, et al.
Publicado: (2022)